Advisors Asset Management Inc. Sells 166 Shares of Chemed Co. (NYSE:CHE)

Advisors Asset Management Inc. trimmed its position in shares of Chemed Co. (NYSE:CHE) by 4.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,328 shares of the company’s stock after selling 166 shares during the quarter. Advisors Asset Management Inc.’s holdings in Chemed were worth $2,000,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of CHE. Kayne Anderson Rudnick Investment Management LLC increased its position in Chemed by 2.6% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 580,316 shares of the company’s stock valued at $314,868,000 after acquiring an additional 14,651 shares during the last quarter. William Blair Investment Management LLC lifted its stake in shares of Chemed by 2.7% in the 2nd quarter. William Blair Investment Management LLC now owns 475,372 shares of the company’s stock worth $257,927,000 after purchasing an additional 12,705 shares during the period. Impax Asset Management Group plc boosted its holdings in shares of Chemed by 4.7% in the third quarter. Impax Asset Management Group plc now owns 332,757 shares of the company’s stock worth $199,977,000 after buying an additional 14,814 shares during the last quarter. TD Asset Management Inc grew its position in Chemed by 10.9% during the second quarter. TD Asset Management Inc now owns 282,753 shares of the company’s stock valued at $153,416,000 after buying an additional 27,800 shares during the period. Finally, Epoch Investment Partners Inc. increased its holdings in Chemed by 22.1% during the second quarter. Epoch Investment Partners Inc. now owns 223,134 shares of the company’s stock valued at $121,068,000 after buying an additional 40,358 shares during the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Chemed

In related news, EVP Nicholas Michael Westfall sold 1,713 shares of the company’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $569.35, for a total transaction of $975,296.55. Following the completion of the transaction, the executive vice president now owns 6,109 shares in the company, valued at approximately $3,478,159.15. This represents a 21.90 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the transaction, the chief executive officer now directly owns 103,735 shares of the company’s stock, valued at $62,117,555.35. The trade was a 1.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 4,113 shares of company stock valued at $2,411,905 over the last 90 days. Company insiders own 3.32% of the company’s stock.

Analyst Upgrades and Downgrades

CHE has been the topic of several analyst reports. Royal Bank of Canada dropped their price target on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th. StockNews.com downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Friday.

Chemed Trading Up 1.4 %

Chemed stock opened at $570.96 on Monday. Chemed Co. has a 12-month low of $523.33 and a 12-month high of $654.62. The firm has a market capitalization of $8.59 billion, a price-to-earnings ratio of 28.85, a P/E/G ratio of 2.39 and a beta of 0.46. The firm has a 50 day moving average of $579.08 and a 200 day moving average of $565.00.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm had revenue of $606.18 million during the quarter, compared to analysts’ expectations of $612.22 million. During the same period last year, the company earned $5.32 earnings per share. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. On average, analysts predict that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Monday, November 18th will be given a $0.50 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $2.00 annualized dividend and a dividend yield of 0.35%. Chemed’s payout ratio is 10.11%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.